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(COAT) trial those participants who started ART 1-2 weeks after
cryptococcal diagnosis had a 73% higher mortality rate compared
with those started 5-6 weeks after diagnosis. Immune reconstitu-
tion inﬂammatory syndrome (IRIS) is reported in 20% of patients
with cryptococcal meningitis starting ART; management of this
condition will be discussed.
Among all patients with CD4 counts < 100 presenting for HIV
care in sub-Saharan Africa 2-20% are found to have cryptococcal
antigenaemia even though most do not have clinical features of
meningitis at the time. Observational data and ﬁndings of a cluster-
randomised trial suggest that pre-emptive ﬂuconazole for such
antigenaemic patientsmaypreventmeningitis anddeath. The opti-
mal dose and duration of ﬂuconazole for this indication needs to be
deﬁned.
Other important opportunistic disease contributing to HIV-
related mortality in the region (pneumocystis pneumonia,
Karposi’s sarcoma and chronic gastro-enteritis) will be discussed,
but this presentation will not address HIV-associated tuberculosis.
http://dx.doi.org/10.1016/j.ijid.2016.02.044
Type: Invited Presentation
Final Abstract Number: 06.003
Session: HIV - Management of Opportunistic Infections in Low-and-
Middle-Income Countries
Date: Thursday, March 3, 2016
Time: 10:15-12:15
Room: G.01-03
Challenges in the management of opportunistic
infections: Focus on Southeast Asia
A. Kamarulzaman
University of Malaya, Kuala Lumpur, Malaysia
Abstract: Latepresenters intoHIVcare remaincommon inSouth
East Asia. In an analysis of more than 3700 patients in an Asian
observational cohort, more than 72% were late presenters ie pre-
senting into HIV care for the ﬁrst time with CD4 of < 200 cells/mm3
or with an AIDS deﬁning illness. Consequently physicians in South
East Asia continue to manage patients who present with a myriad
of opportunistic infections including toxoplasmosis, CMV infection,
disseminated fungal infections and tuberculosis. Advanced HIV
infection also leads to an increased risk for immune reconstitution
syndrome which may present as a diagnostic and or therapeutic
challenge in these patients.
Apart from late presentation, substance use disorder and coin-
fections with hepatitis B and C are also relatively common in the
region and can lead to additional challenges in the management
of opportunistic infections and provision of antiretroviral therapy.
Drug-drug interaction and hepatotoxicity are amongst the difﬁcul-
ties that may be encountered in these patients.
A further important consideration when managing patients
with opportunistic infections is the optimal timing for the initiation
of antiretroviral therapy. In recent years several large clinical tri-
als have been performed to address this issue especially in relation
to tuberculosis. These and data from observational studies would
suggest that early initiation of antiretroviral therapy in the setting
of active opportunistic infections confer survival beneﬁts with the
exception of tuberculous meningitis and cryptococcal meningitis.
Despite the advances that havebeenmade in antiretroviral ther-
apy and a global call for early and immediate initiation of treatment
on diagnosis, a large majority of patients continue to present with
late stage diseasewith opportunistic infections. Physicians in South
East Asia and other low and middle income countries need to con-
tinue be equipped with the ability to diagnose and manage these
infections effectively.
http://dx.doi.org/10.1016/j.ijid.2016.02.045
Type: Invited Presentation
Final Abstract Number: 06.004
Session: HIV - Management of Opportunistic Infections in Low-and-
Middle-Income Countries
Date: Thursday, March 3, 2016
Time: 10:15-12:15
Room: G.01-03
The challenge of opportunistic infections: Focus
on South America
J. Torres
Universidad Central de Venezuela, Caracas,
Venezuela
Abstract: Some opportunistic diseases are either exclusive or
more commonly observed in South American AIDS patients than
in those from different parts of the world. Interactions between
HIV and endemic parasitic and other locally prevalent pathogens
occur frequently in South America. However, knowledge about the
impact of these interactions has been accumulating only recently.
HIV infection may alter the natural history of tropical diseases
in different ways. Diagnosis and treatment may be altered and an
increased pathogen burdenmay augmentmorbidity andmortality.
The impact that tropical diseaseshaveon thecourseofHIV infection
may also be deleterious. Many intercurrent infections increase the
HIV viral load enhancing the progression of HIV disease and the
risk of transmission of HIV to non-infected individuals. Similarly,
chronic immunomodulation by pathogens, such as helminths and
protozoa, may considerably accelerate the natural history of HIV
infection.
Characteristics of coinfection in the region with HIV and some
emblematic endemic pathologies, such as paracoccidioidomycosis,
histoplasmosis, Chagas’ disease, visceral leishmaniasis, strongy-
loidiasis and HTLV1, as well as some unique challenges posed by
them, are reviewed in detail.
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Abstract: The Middle East respiratory syndrome coronavirus
(MERS-CoV) is a novel enzootic beta coronavirus that was ﬁrst
described in September 2012. The clinical spectrum of MERS-CoV
infection in humans ranges from an asymptomatic or mild respira-
tory illness to severe pneumonia and multi-organ failure; overall
